Cost-effectiveness of expanded latent TB infection testing and treatment: Lynn City, Massachusetts, USA.

Autor: Beeler Asay GR; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA., Woodruff R; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA., Sanderson DM; Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Boston, MA, USA., Fisher CF; Institute for Community Health, Malden, MA, USA., Marks SM; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA., Green VD; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA., Tibbs AM; Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Boston, MA, USA., Hill AN; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA., Haptu HH; Lynn Community Health Center, Lynn, MA, USA., McManus D; Lynn Community Health Center, Lynn, MA, USA., Paradise RK; Institute for Community Health, Malden, MA, USA., Auguste-Nelson C; Institute for Community Health, Malden, MA, USA., Cochran JJ; Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Boston, MA, USA.

Publikováno v: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2024 Jan 01; Vol. 28 (1), pp. 21-28.

Visceral Adiposity Index as a Measure of Cardiovascular Disease in Persons With Human Immunodeficiency Virus.

Autor: Thomas TS; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Dunderdale C; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Lu MT; Cardiovascular Imaging Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Walpert AR; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Shen G; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Young MCH; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Torriani M; Division of Musculoskeletal Imaging and Intervention, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Chu JT; Division of Infectious Diseases, Mass General Brigham and Harvard Medical School, Boston, Massachusetts, USA., Haptu HH; Division of Infectious Diseases, Mass General Brigham and Harvard Medical School, Boston, Massachusetts, USA., Manandhar M; Division of Infectious Diseases, Mass General Brigham and Harvard Medical School, Boston, Massachusetts, USA., Wurcel A; Division of Infectious Diseases, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA., Adler GK; Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital and Harvard Medical School,  Boston, Massachusetts, USA., Grinspoon SK; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Srinivasa S; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2023 Jul 24; Vol. 10 (8), pp. ofad398. Date of Electronic Publication: 2023 Jul 24 (Print Publication: 2023).